Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Reforgene Medicine
company
About
Reforgene Medicine is a biomedical company that uses gene editing and genomic technology to develop drugs intended to cure genetic diseases.
- 1 - 10
Highlights
Details
- Last Funding Type
- Series A
- Industries
- Biotechnology,Health Care,Medical,Therapeutics
- Founded date
- Jan 1, 2019
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Reforgene Medicine is a biomedical company that uses gene editing and genomic technology to develop new drugs intended to cure genetic diseases.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
—
Reforgene Medicine has raised a total of
—
in funding over 2 rounds. Their latest funding was raised on
Sep 16, 2021 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 16, 2021 | Series A | — | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Reforgene Medicine is funded by 1 investors.
China Merchants Securities
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
China Merchants Securities
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
